Institution
Hanall Biopharma (South Korea)
KRcompany
Recent research
- Health & MedicineOpen access
OBJECTIVE: This study was undertaken to assess long-term efficacy, safety, and tolerability of adjunctive cenobamate in an open-label extension (OLE) of a randomized, double-blind, placebo-controlled, dose-response study (NCT04557085; YKP3089C035 [Study C035]) in Asian patients w...
- Engineering & TechnologyOpen access
Abstract Reliable particle counting is critical for applications such as clinical monitoring and cell therapy manufacturing. However, various particle counters using different measurement principles are employed, and the absence of reference materials makes standardization challe...